CMF SpinaLogic® Brief Prescribing Information | Close Window |
CMF SpinaLogic is a portable, battery-powered microcontrolled, noninvasive bone growth stimulator indicated as an adjunct electromagnetic treatment to primary lumbar spinal fusion surgery for one or two levels.
Demand-type pacemaker and implantable cardiovertor defibrilator (ICD) operation may be adversely affected by exposure to combined static and dynamic magnetic fields. Physicians should not prescribe CMF SpinaLogic for patients with such devices.
The safety and effectiveness of SpinaLogic in pregnant women have not been studied, and the effects of the device on the mother or the developing fetus are unknown, thus, this device should not be used in pregnant women. If a woman becomes pregnant during treatment with CMF SpinaLogic, treatment should be discontinued immediately.
No known significant adverse effects have resulted from the use of this device. Clinical studies, animal studies, and tissue culture experiments conducted with the CMF SpinaLogic Bone Growth Stimulator magnetic fields have not indicated any evidence of significant adverse effects.
Federal law (USA) restricts this device to sale by or on the order of a physician. For full prescribing information, contact DJO, LLC.